Form 4: Phreesia's COO, Evan Roberts, Executes Stock Sales Under 10b5-1 Plan

Evan Roberts, Chief Operating Officer of Phreesia, Inc., sold shares of common stock on February 18 and 19, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 18, 2025, Evan Roberts, the Chief Operating Officer of Phreesia, Inc., sold 3,519 shares of common stock at a weighted average price of $30.0551 per share.
• The sales were executed under a Rule 10b5-1 trading plan adopted on July 17, 2024.
• Following the transaction on February 18, Roberts beneficially owned 741,197 shares of Phreesia's common stock.
• On February 19, 2025, Roberts sold an additional 177 shares at $30 per share, resulting in a beneficial ownership of 741,020 shares.
• The price range for the February 18 sales was between $30.00 and $30.34 per share.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock sales by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider stock sales. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on Phreesia's stock will likely be minimal unless these sales are unusually large or frequent.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• The use of a 10b5-1 trading plan is a common and accepted method for corporate insiders to manage their stock sales, similar to practices seen at companies like Veeva Systems or athenahealth.
• The size of the transactions is relatively small compared to the overall volume of Phreesia's stock, suggesting limited impact.

Stakeholder Impact

• The stock sales could have a minor, short-term impact on shareholders if they perceive it negatively, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Phreesia, Evan Roberts, Form 4, stock sale, Rule 10b5-1, insider trading, common stock, beneficial ownership